Accuracy of Fluorodeoxyglucose-PET Imaging for Differentiating Benign From Malignant Pleural Effusions
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Clinical utility of 18-fluorodeoxyglucose positron emission tomography/computed tomography in malignant pleural mesotheliomaExperimental and Therapeutic Medicine, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Impact of Dual-Time-Point F-18 FDG PET/CT in the Assessment of Pleural Effusion in Patients With Non-Small-Cell Lung CancerClinical Nuclear Medicine, 2011
- Pearls and myths in pleural fluid analysisRespirology, 2010
- Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related Benign Pleural Disease: An Observational Pilot StudyJournal of Thoracic Oncology, 2009
- The Role of Positron Emission Tomography/Computed Tomography in the Diagnosis of Pleural DiseasesThe Thoracic and Cardiovascular Surgeon, 2009
- 18F-FDG PET imaging in assessing exudative pleural effusionsNuclear Medicine Communications, 2006
- Differentiation Between Malignant and Benign Pleural Effusion in Patients With Extra-Pleural Primary MalignanciesInvestigative Radiology, 2005
- Assessment of18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseasesEuropean Respiratory Journal, 2004
- Evaluation of pleural diseases with FDG-PET imaging: preliminary reportThorax, 1997